Trulieve Cannabis(DE:F09)
€9.54-0.62 (-6.10%)
DE:F09
Trulieve Cannabis financials statements
€9.54
At close:-0.62 (-6.10%)
Trulieve Cannabis (F09) Ratios
18 Followers
Trulieve Cannabis Ratios
DE:F09's free cash flow for Q3 2026 was $45.43M. For the 2026 fiscal year, DE:F09's free cash flow was decreased by $-29.03M and operating cash flow was $74.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.43 | 4.37 | 4.16 | 2.83 | 3.10 |
| Quick Ratio | 2.52 | 2.69 | 2.30 | 1.41 | 1.85 |
| Cash Ratio | 2.01 | 1.72 | 1.75 | 1.01 | 1.37 |
| Solvency Ratio | 0.04 | 0.01 | -0.26 | -0.01 | 0.08 |
| Operating Cash Flow Ratio | 2.15 | 1.96 | 1.76 | 0.11 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 66.92 | 79.68 | 53.70 | 1.85 | 1.28 |
| Net Current Asset Value | $ -990.37M | $ -1.02B | $ -843.09M | $ -878.30M | $ -739.08M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.29 | 0.29 | 0.30 | 0.25 |
| Debt-to-Equity Ratio | 0.49 | 0.65 | 0.56 | 0.53 | 0.40 |
| Debt-to-Capital Ratio | 0.33 | 0.40 | 0.36 | 0.35 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.27 | 0.25 | 0.25 | 0.18 |
| Financial Leverage Ratio | 2.32 | 2.28 | 1.93 | 1.76 | 1.59 |
| Debt Service Coverage Ratio | 1.78 | 1.30 | -2.03 | 0.91 | 3.51 |
| Interest Coverage Ratio | 2.34 | 1.57 | -2.72 | 1.49 | 6.76 |
| Debt to Market Cap | 0.14 | 0.49 | 0.40 | 0.46 | 0.13 |
| Interest Debt Per Share | 3.28 | 4.66 | 3.78 | 5.89 | 6.23 |
| Net Debt to EBITDA | 0.94 | 2.07 | -26.90 | 3.41 | 2.22 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.21% | 60.32% | 52.13% | 55.01% | 60.33% |
| EBIT Margin | 13.12% | 8.84% | -17.97% | 4.37% | 21.89% |
| EBITDA Margin | 27.80% | 23.83% | -1.95% | 19.34% | 30.22% |
| Operating Profit Margin | 12.56% | 8.24% | -19.63% | 8.82% | 20.99% |
| Pretax Profit Margin | 7.74% | 3.60% | -25.20% | -3.49% | 17.42% |
| Net Profit Margin | -9.85% | -13.07% | -46.65% | -16.54% | 1.92% |
| Continuous Operations Profit Margin | -9.87% | -13.05% | -38.60% | -14.73% | 3.25% |
| Net Income Per EBT | -127.23% | -363.12% | 185.14% | 473.67% | 11.03% |
| EBT Per EBIT | 61.67% | 43.68% | 128.39% | -39.58% | 83.02% |
| Return on Assets (ROA) | -4.32% | -5.40% | -19.30% | -6.03% | 0.53% |
| Return on Equity (ROE) | -10.02% | -12.30% | -37.24% | -10.62% | 0.84% |
| Return on Capital Employed (ROCE) | 5.77% | 3.58% | -8.48% | 3.43% | 6.07% |
| Return on Invested Capital (ROIC) | -7.28% | -12.85% | -8.40% | 3.40% | 0.64% |
| Return on Tangible Assets | -8.23% | -10.16% | -39.67% | -12.86% | 1.18% |
| Earnings Yield | -7.00% | -15.69% | -43.63% | -14.47% | 0.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 58.47 | 51.48 | 87.29 | 171.36 | 46.48 |
| Payables Turnover | 17.55 | 23.27 | 19.14 | 35.18 | 25.18 |
| Inventory Turnover | 1.94 | 2.03 | 2.54 | 1.87 | 1.75 |
| Fixed Asset Turnover | 1.41 | 1.32 | 1.36 | 1.27 | 0.96 |
| Asset Turnover | 0.44 | 0.41 | 0.41 | 0.36 | 0.28 |
| Working Capital Turnover Ratio | 0.00 | 2.86 | 3.03 | 3.36 | 3.45 |
| Cash Conversion Cycle | 173.61 | 170.80 | 129.01 | 186.62 | 201.41 |
| Days of Sales Outstanding | 6.24 | 7.09 | 4.18 | 2.13 | 7.85 |
| Days of Inventory Outstanding | 188.16 | 179.40 | 143.90 | 194.87 | 208.05 |
| Days of Payables Outstanding | 20.80 | 15.68 | 19.07 | 10.38 | 14.49 |
| Operating Cycle | 194.40 | 186.49 | 148.08 | 197.00 | 215.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.43 | 1.43 | 0.87 | 0.12 | 0.09 |
| Free Cash Flow Per Share | 1.11 | 0.61 | 0.63 | -0.86 | -2.06 |
| Dividend Paid and CapEx Coverage Ratio | 4.51 | 1.76 | 3.63 | 0.13 | 0.04 |
| Capital Expenditure Coverage Ratio | 4.51 | 1.76 | 3.63 | 0.13 | 0.04 |
| Operating Cash Flow Coverage Ratio | 0.48 | 0.33 | 0.25 | 0.02 | 0.02 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.23 | 0.18 | 0.02 | 0.01 |
| Free Cash Flow Yield | 12.77% | 11.82% | 12.12% | -11.39% | -7.90% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.25 | -6.37 | -2.29 | -6.91 | 205.83 |
| Price-to-Sales (P/S) Ratio | 1.41 | 0.83 | 1.07 | 1.14 | 3.96 |
| Price-to-Book (P/B) Ratio | 1.43 | 0.78 | 0.85 | 0.73 | 1.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.83 | 8.46 | 8.25 | -8.78 | -12.66 |
| Price-to-Operating Cash Flow Ratio | 6.09 | 3.64 | 5.98 | 61.37 | 287.76 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.10 | -0.02 | 0.01 | -2.70 |
| Enterprise Value Multiple | 6.00 | 5.57 | -81.84 | 9.32 | 15.30 |
| Enterprise Value | 1.97B | 1.57B | 1.80B | 2.23B | 4.34B |
| EV to EBITDA | 6.00 | 5.57 | -81.84 | 9.32 | 15.30 |
| EV to Sales | 1.67 | 1.33 | 1.59 | 1.80 | 4.62 |
| EV to Free Cash Flow | 9.28 | 13.48 | 12.29 | -13.84 | -14.80 |
| EV to Operating Cash Flow | 7.22 | 5.80 | 8.91 | 96.74 | 336.48 |
| Tangible Book Value Per Share | -0.73 | -0.50 | 0.03 | 0.66 | 1.85 |
| Shareholders’ Equity Per Share | 6.07 | 6.63 | 6.12 | 10.31 | 15.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 2.28 | 4.63 | -0.53 | -3.74 | 0.89 |
| Revenue Per Share | 6.17 | 6.24 | 4.89 | 6.62 | 6.58 |
| Net Income Per Share | -0.61 | -0.82 | -2.28 | -1.10 | 0.13 |
| Tax Burden | -1.27 | -3.63 | 1.85 | 4.74 | 0.11 |
| Interest Burden | 0.59 | 0.41 | 1.40 | -0.80 | 0.80 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.38 | 0.43 | 0.13 | 0.14 | 0.11 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Income Quality | -2.23 | -1.69 | -0.38 | -0.09 | 0.74 |
Currency in USD
